Monoclonal antibody for use in drug resistant cancers and production thereof
US5087560A · kind A · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 1990 |
| Grant date | Feb 11, 1992 |
| Priority date | — |
| Expiry date | Oct 1, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/864
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Monoclonal antibodies are disclosed that may be produced by hybridomas obtained by fusing a mouse spleen cell immunized with an ADRIAMYCIN.RTM.-resistant human tumor cell and a mouse myeloma cell and which inhibit selectively the growth of cancer cells possessing pleiotropic drug resistance or enhance their sensitivity to said drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.